비교리스트

 카트 문의
시장보고서
상품코드
1650776

세계의 바이오뱅크 시장

Biobanks
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 402 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오뱅크 세계 시장 규모는 2030년까지 1,433억 달러에 달할 전망

2024년 916억 달러로 추정되는 바이오뱅크 세계 시장은 2030년에는 1,433억 달러에 달할 것으로 예상되며, 2024-2030년 분석 기간 동안 7.7%의 CAGR로 성장할 것으로 예상됩니다. 본 보고서에서 분석하는 부문 중 하나인 물리적/실제 바이오뱅크는 CAGR 7.3%를 기록하여 분석 기간 종료 시점에 1,084억 달러에 도달할 것으로 예상됩니다. 가상 바이오뱅크 분야의 성장률은 분석 기간 동안 CAGR 9.2%로 추정됩니다.

미국 시장은 298억 달러, 중국은 CAGR 8.8%로 성장 전망

미국의 바이오뱅크 시장 규모는 2024년 298억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 151억 달러의 시장 규모에 도달할 것으로 예상되며, 2024-2030년 분석 기간 동안 CAGR은 8.8%에 달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 6.5%와 7.0%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 7.6%로 성장할 것으로 예상됩니다.

세계 바이오뱅크 시장 - 주요 동향 및 촉진요인 정리

바이오뱅크는 혈액, 조직, DNA, 기타 체액 등의 생물학적 샘플을 수집, 보관, 관리하고 연구 및 임상 연구에 사용하는 전문 보관소입니다. 이러한 샘플은 관련 데이터와 함께 의학 연구 발전, 질병 이해, 새로운 치료법 및 진단법 개발에 매우 귀중한 자원입니다. 바이오뱅크는 유전체학, 맞춤의료, 역학, 중개연구 등 다양한 연구 분야를 지원하고 있습니다. 질병 기전 연구, 바이오마커 식별, 신약 및 치료법 테스트에 필수적인 고품질의 잘 특성화된 시료에 대한 접근을 연구자들에게 제공합니다.

바이오뱅크의 개발과 활용은 기술 및 데이터 관리의 발전으로 크게 향상되었습니다. 최신 바이오뱅크는 시료의 수집, 처리, 저장, 검색을 위해 첨단 시스템을 채택하여 시료의 무결성과 추적성을 보장합니다. 하이스루풋 시퀀싱, 바이오인포매틱스, 데이터 분석의 통합을 통해 바이오뱅크의 샘플에서 귀중한 지식을 추출하여 의학 연구의 비약적인 발전을 촉진할 수 있습니다. 또한, 표준화된 프로토콜과 품질 관리 수단의 도입으로 연구 결과의 일관성과 재현성을 보장합니다. 또한, 대규모 집단 조사 및 종단적 연구에서도 중요한 역할을 수행하여 건강과 질병의 원인이 되는 유전적, 환경적, 생활습관적 요인을 이해하기 위한 기반을 제공하고 있습니다.

바이오뱅크 시장의 성장은 몇 가지 요인에 의해 이루어지고 있습니다. 첫째, 암, 심혈관질환과 같은 만성 및 복합 질환의 유병률 증가는 새로운 치료법과 진단법 연구를 지원하기 위한 바이오뱅크에 대한 수요를 촉진하고 있습니다. 둘째, 맞춤형 의료와 정밀 의료의 부상으로 표적 치료 및 중재법 개발에 사용할 수 있는 잘 특성화된 생물학적 샘플의 필요성이 증가하고 있습니다. 셋째, 유전학 및 유전체 연구에 대한 관심이 높아짐에 따라 질병의 유전적 기반 연구와 새로운 바이오마커 발굴을 위한 바이오뱅크 샘플의 활용이 확대되고 있습니다. 또한, 자동 저장 시스템 및 고급 데이터 관리 플랫폼을 포함한 바이오뱅크 기술의 발전으로 바이오뱅크의 효율성과 능력이 향상되고 있습니다. 마지막으로, 학계, 의료 기관, 산업체 간의 자금 지원과 협력의 증가는 바이오뱅크의 설립과 확장을 지원하고, 시장 성장을 촉진하며, 생물의학 연구의 혁신을 촉진하고 있습니다.

부문

유형(물리적/실제, 가상), 제품(바이오뱅킹 기기, 바이오뱅킹 소모품, 실험실 정보관리 시스템), 용도(치료제, 신약개발/임상연구, 임상진단, 기타 용도)

조사 대상 기업 사례(총 99건)

  • AMS Biotechnology(Europe) Limited
  • Bay Biosciences LLC
  • BioIVT & Elevating Science
  • BioLifeSolutions Inc.
  • Biovault Technical
  • CENTOGENE NV
  • CTI Biotech
  • Cureline, Inc.
  • Firalis S.A.
  • Hamilton Company
  • Merck KGaA
  • ProteoGenex, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation, Inc.
  • VWR International LLC

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.02.21

Global Biobanks Market to Reach US$143.3 Billion by 2030

The global market for Biobanks estimated at US$91.6 Billion in the year 2024, is expected to reach US$143.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. Growth in the Virtual Biobanks segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Billion While China is Forecast to Grow at 8.8% CAGR

The Biobanks market in the U.S. is estimated at US$29.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.1 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Biobanks Market - Key Trends & Drivers Summarized

Biobanks are specialized repositories that collect, store, and manage biological samples such as blood, tissue, DNA, and other bodily fluids for use in research and clinical studies. These samples, along with associated data, are invaluable resources for advancing medical research, understanding diseases, and developing new treatments and diagnostics. Biobanks support a wide range of research areas, including genomics, personalized medicine, epidemiology, and translational research. They provide researchers with access to high-quality, well-characterized specimens that are critical for studying disease mechanisms, identifying biomarkers, and testing new drugs and therapies.

The development and utilization of biobanks have been significantly enhanced by advancements in technology and data management. Modern biobanks employ sophisticated systems for sample collection, processing, storage, and retrieval, ensuring the integrity and traceability of specimens. The integration of high-throughput sequencing, bioinformatics, and data analytics enables the extraction of valuable insights from biobank samples, facilitating breakthroughs in medical research. Moreover, the implementation of standardized protocols and quality control measures ensures the consistency and reproducibility of research findings. Biobanks also play a crucial role in large-scale population studies and longitudinal research, providing a foundation for understanding the genetic, environmental, and lifestyle factors that contribute to health and disease.

The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers. Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.

SCOPE OF STUDY:

The report analyzes the Biobanks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Physical / Real, Virtual); Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems); Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 99 Featured) -

  • AMS Biotechnology (Europe) Limited
  • Bay Biosciences LLC
  • BioIVT & Elevating Science
  • BioLifeSolutions Inc.
  • Biovault Technical
  • CENTOGENE NV
  • CTI Biotech
  • Cureline, Inc.
  • Firalis S.A.
  • Hamilton Company
  • Merck KGaA
  • ProteoGenex, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation, Inc.
  • VWR International LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Growing Focus on Early Diagnosis and Treatment of Chronic Diseases and Genetic Conditions Cornerstone for the Growth of Biobanks
    • Global Economic Update
    • Competition
    • Biobanks - Global Key Competitors Percentage Market Share in 2024 (E)
    • Biobanks Competitor Market Share Scenario Worldwide (in %): 2022E
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Research Focus on Regenerative Medicine Expands Opportunities for Biobanks
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Uptrend in Translational Research and Personalized Medicine to Benefit Demand
    • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Biobanks: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
    • Growing Focus on Personalized Medicine for Oncology Domain Raises the Importance of Biobanking Services
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Biobanks Poised to Benefit from the Increasingly Robust Outlook for Digital Health
    • Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
    • Rise Genomic Research Initiatives Drives Growth Opportunities
    • Technological Advancements Bring in Transformative Changes
    • AI and ML Advancements to Benefit Biobanks
    • Biobanks Enter the Age of Big Data
    • Use of Laboratory Information Management System Software Gains Momentum
    • Biobanks Turn to Customized LIMS Software
    • Biobanking Jumpstarts to a New Era with Imaging Biobanks
    • Imaging Biobanks Dedicated to Radiogenomics
    • Virtual Biobanks Emerge as Bankable Option for Access to Research Resources
    • Strong Outlook for Gene Therapy to Drive Demand for Biobanking Services
    • World Gene Therapy Market in US$ Million:L 2020, 2022, 2024, 2026, 2028, 2030
    • Uptrend in Drug Discovery Research Builds Robust Momentum
    • Global Drug Discovery Market Size (in US$ Billion) for the Years 2020, 2022, 2024, 2026, 2028, ad 2030
    • Human iPSC Banks: A Review of Emerging Opportunities
    • Human iPSC Banks Worldwide: An Overview
    • Automated Storage Systems Gain Importance
    • Prospective Collection to Gather Steam
    • Rise in R&D Initiatives in Life Sciences & Pharmaceutical Industries Boosts Prospects
    • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Physical / Real by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Physical / Real by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Physical / Real by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Virtual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Virtual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Virtual by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biobanking Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biobanking Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Biobanking Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Laboratory Information Management Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Laboratory Information Management Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Laboratory Information Management Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Drug Discovery & Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Biobanks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Biobanks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Biobanks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 80: France Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 107: UK Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제